
Ecstasy Addiction
Ecstasy
users may encounter problems similar to those experienced by amphetamine and cocaine
users, including addiction. In addition to its rewarding effects, ecstasy's psychological
effects can include confusion, depression, sleep problems, anxiety, and paranoia
during, and sometimes weeks after, taking the drug. Physical effects can include
muscle tension, involuntary teeth-clenching, nausea, blurred vision, faintness,
and chills or sweating. Increases in heart rate and blood pressure are a special
risk for people with circulatory or heart disease. Ecstasy-related fatalities
at raves have been reported. The stimulant effects of the drug, which enable the
user to dance for extended periods, combined with the hot, crowded conditions
usually found at raves can lead to dehydration, hyperthermia, and heart or kidney
failure. Ecstasy use damages brain serotonin neurons. Serotonin is thought to
play a role in regulating mood, memory, sleep, and appetite. Recent research indicates
heavy ecstasy use causes persistent memory problems in humans. Long-term
brain injury from use of "ecstasy"
The designer drug "Ecstasy," or MDMA, causes long-lasting damage to
brain areas that are critical for thought and memory, according to new research
findings in the June 15 issue of The Journal of Neuroscience. In an experiment
with red squirrel monkeys, researchers at The Johns Hopkins University demonstrated
that 4 days of exposure to the drug caused damage that persisted 6 to 7 years
later. These findings help to validate previous research by the Hopkins team in
humans, showing that people who had taken ecstasy scored lower on memory tests.
"The
serotonin system, which is compromised by ecstasy, is fundamental to the brain's
integration of information and emotion," says Dr. Alan I. Leshner, director
of the National Institute on Drug Abuse (NIDA), National Institutes of Health,
which funded the research. "At the very least, people who take ecstasy, even
just a few times, are risking long-term, perhaps permanent, problems with learning
and memory."
The researchers found that the nerve cells (neurons) damaged by ecstasy are those
that use the chemical serotonin to communicate with other neurons. The Hopkins
team had also previously conducted brain imaging research in human ecstasy users,
in collaboration with the National Institute of Mental Health, which showed extensive
damage to serotonin neurons.
MDMA (3,4-methylenedioxymethamphetamine) has a stimulant effect, causing similar
euphoria and increased alertness as cocaine and amphetamine. It also causes mescaline-like
psychedelic effects. First used in the 1980s, MDMA is often taken at large, all-night
"rave" parties.
In this new study, the Hopkins researchers administered either MDMA or salt water
to the monkeys twice a day for 4 days. After 2 weeks, the scientists examined
the brains of half of the monkeys. Then, after 6 to 7 years, the brains of the
remaining monkeys were examined, along with age-matched controls.
In the brains of the monkeys examined soon after the 2-week period, Dr. George
Ricaurte and his colleagues found that MDMA caused more damage to serotonin neurons
in some parts of the brain than in others. Areas particularly affected were the
neocortex (the outer part of the brain where conscious thought occurs) and the
hippocampus (which plays a key role in forming long-term memories).
This damage was also apparent, although to a lesser extent, in the brains of monkeys
who had received MDMA during the same 2-week period but who had received no MDMA
for 6 to 7 years. In contrast, no damage was noticeable in the brains of those
who had received salt water. "Some
recovery of serotonin neurons was apparent in the brains of the monkeys given
MDMA 6 to 7 years previously," says
Dr. Ricaurte, "but this recovery occurred only in certain regions, and was
not always complete. Other brain regions showed no evidence of recovery whatsoever."
Ecstasy
damages the brain and impairs memory in humans
A NIDA-supported study has provided the first direct evidence that chronic use
of MDMA, popularly known as "ecstasy," causes brain damage in people.
Using advanced brain imaging techniques, the study found that MDMA harms neurons
that release serotonin, a brain chemical thought to play an important role in
regulating memory and other functions. In a related study, researchers found that
heavy MDMA users have memory problems that persist for at least 2 weeks after
they have stopped using the drug. Both studies suggest that the extent of damage
is directly correlated with the amount of MDMA use.
"The message
from these studies is that MDMA does change the brain and it looks like there
are functional consequences to these changes," says Dr. Joseph Frascella
of NIDA's Division of Treatment Research and Development. That message is particularly
significant for young people who participate in large, all-night dance parties
known as "raves," which are popular in many cities around the Nation.
NIDA's epidemiologic studies indicate that MDMA (3,4-methylenedioxymethamphetamine)
use has escalated in recent years among college students and young adults who
attend these social gatherings. These
brain scans show the amount of serotonin activity over a 40-minute period in a
non-MDMA user (left) and an MDMA user (right). Dark areas in the MDMA user's brain
show damage due to chronic MDMA use.
In the brain imaging study, researchers used positron emission tomography (PET)
to take brain scans of 14 MDMA users who had not used any psychoactive drug, including
MDMA, for at least 3 weeks. Brain images also were taken of 15 people who had
never used MDMA. Both groups were similar in age and level of education and had
comparable numbers of men and women.
In people who had used MDMA, the PET images showed significant reductions in the
number of serotonin transporters, the sites on neuron surfaces that reabsorb serotonin
from the space between cells after it has completed its work. The lasting reduction
of serotonin transporters occurred throughout the brain, and people who had used
MDMA more often lost more serotonin transporters than those who had used the drug
less.
Previous PET studies with baboons also produced images indicating MDMA had induced
long-term reductions in the number of serotonin transporters. Examinations of
brain tissue from the animals provided further confirmation that the decrease
in serotonin transporters seen in the PET images corresponded to actual loss of
serotonin nerve endings containing transporters in the baboons' brains. "Based
on what we found with our animal studies, we maintain that the changes revealed
by PET imaging are probably related to damage of serotonin nerve endings in humans
who had used MDMA," says Dr. George Ricaurte of The Johns Hopkins Medical
Institutions in Baltimore. Dr. Ricaurte is the principal investigator for both
studies, which are part of a clinical research project that is assessing the long-term
effects of MDMA. "The
real question in all imaging studies is what these changes mean when it comes
to functional consequences," says NIDA's Dr. Frascella. To help answer that
question, a team of researchers, which included scientists from Johns Hopkins
and the National Institute of Mental Health who had worked on the imaging study,
attempted to assess the effects of chronic MDMA use on memory. In this study,
researchers administered several standardized memory tests to 24 MDMA users who
had not used the drug for at least 2 weeks and 24 people who had never used the
drug. Both groups were matched for age, gender, education, and vocabulary scores.
The study found that, compared to the nonusers, heavy MDMA users had significant
impairments in visual and verbal memory. As had been found in the brain imaging
study, MDMA's harmful effects were dose-related the more MDMA people used, the
greater difficulty they had in recalling what they had seen and heard during testing.
The memory impairments found in MDMA users are among the first functional consequences
of MDMA-induced damage of serotonin neurons to emerge. Recent studies conducted
in the United Kingdom also have reported memory problems in MDMA users assessed
within a few days of their last drug use. "Our study extends the MDMA-induced
memory impairment to at least 2 weeks since last drug use and thus shows that
MDMA's effects on memory cannot be attributed to withdrawal or residual drug effects,"
says Dr. Karen Bolla of Johns Hopkins, who helped conduct the study.
The Johns Hopkins/NIMH research-ers also were able to link poorer memory performance
by MDMA users to loss of brain serotonin function by measuring the levels of a
serotonin metabolite in study participants' spinal fluid. These measurements showed
that MDMA users had lower levels of the metabolite than people who had not used
the drug; that the more MDMA they reported using, the lower the level of the metabolite;
and that the people with the lowest levels of the metabolite had the poorest memory
performance. Taken together, these findings support the conclusion that MDMA-induced
brain serotonin neurotoxicity may account for the persistent memory impairment
found in MDMA users, Dr. Bolla says.
Research on the functional consequences of MDMA-induced damage of serotonin-producing
neurons in humans is at an early stage, and the scientists who conducted the studies
cannot say definitively that the harm to brain serotonin neurons shown in the
imaging study accounts for the memory impairments found among chronic users of
the drug. However, "that's the concern, and it's certainly the most obvious
basis for the memory problems that some MDMA users have developed," Dr. Ricaurte
says.
Findings from another Johns Hopkins/NIMH study now suggest that MDMA use may lead
to impairments in other cognitive functions besides memory, such as the ability
to reason verbally or sustain attention. Researchers are continuing to examine
the effects of chronic MDMA use on memory and other functions in which serotonin
has been implicated, such as mood, impulse control, and sleep cycles. How long
MDMA-induced brain damage persists and the long-term consequences of that damage
are other questions researchers are trying to answer. Animal studies, which first
documented the neurotoxic effects of the drug, suggest that the loss of serotonin
neurons in humans may last for many years and possibly be permanent. "We
now know that brain damage is still present in monkeys 7 years after discontinuing
the drug," Dr. Ricaurte says. "We don't know just yet if we're dealing
with such a long-lasting effect in people."
If are looking for a addiction treatment rehabilitation program contact www.drug-rehabs.org
|